Ozempic vs Metformin for PCOS Some research shows that GLP-1 agonists may be even more effective for PCOS than Metformin
however, as the baseline risk in the placebo group was relatively low at 4%, the absolute risk difference between the two groups was only 2%
Additionally, GLP-1 medications work differently because they are engineered to stay active much longer, which is why they have a much more powerful and sustained effect on appetite and blood sugar regulation, he said
Around 20% of daily water intake usually comes from food: so when GLP-1 medications suppress hunger and meal sizes shrink, overall fluid intake naturally declines
Indias drug regulator, the CDSCO, has only cleared a research trial for the drug, not a market launch